Topics in Antiviral Medicine^™

Brief Communication

• Current Evidence on Islatravir Drug Resistance and Implications for Future HIV Treatment
  Annemarie M. Wensing, MD, PhD, Vincent Calvez, MD, PhD, Francesca Ceccherini Silberstein, PhD, Charlotte Charpentier, PharmD, PhD, Huldrych F. Günthard, MD, Roger Paredes, MD, PhD, Robert W. Shafer, MD, Douglas D. Richman, MD

Invited Reviews

• Weight Gain and Obesity Management in People With HIV: Pathophysiology, Antiretroviral Therapy Effects, and Clinical Strategies
  Danna Kashlan, MD, MPH, Zoobia Chaudhry, MBBS
• Selected Highlights From the 26th International Workshop on Clinical Pharmacology of HIV, Hepatitis, and Other Antiviral Drugs
  Kimberly K. Scarsi, PharmD, MS, Catia Marzolini, PharmD, PhD, Fiona Marra, FRPharmS (Consultant), PhD, Alice L. Tseng, PharmD, on behalf of the LiON-PK Group
• Interventions and Opportunities to Enhance Aging Among People With HIV: A Focus on Frailty, Sarcopenia, and Intrinsic Capacity
  Evelyn Iriarte, PhD, Kristine M. Erlandson, MD
• Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, and HIV: Implications for Risk, Outcomes, and Care for Neurodivergent People
  Heather M. Relyea Ashley, MD, Sara K. Stuart, MD, Ellen F. Eaton, MD